Document Detail


Management of acute optic neuritis: a survey of neurologists and ophthalmologists in Australia and New Zealand.
MedLine Citation:
PMID:  18976922     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Recent studies suggest that evidence-based medicine is not well translated into everyday practice. Studies of optic neuritis (ON) have generated clear treatment guidelines. Therefore, a survey was mailed to all Australian and New Zealand neurologists and ophthalmologists to evaluate the impact of recent studies on clinical practice. The response rate was 38.9%. Neurologists were more likely to use high dose corticosteroids and disease modifying agents (DMAs), and were more likely to be aware of relevant literature concerning DMAs. Both groups contained a significant minority of practitioners who would use corticosteroids for reasons not substantiated by available evidence. We conclude that most practitioners manage optic neuritis according to existing evidence and guidelines, but many do not. It is essential to instigate high-quality training programs to keep practitioners up-to-date, thereby optimising patient care and justifying the time and expense of large-scale clinical trials.
Authors:
Christian J Lueck; Helen V Danesh-Meyer; Faith J Margrie; Carolyn Drews-Botsch; Olivier Calvetti; Nancy J Newman; Valérie Biousse
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2008-10-30
Journal Detail:
Title:  Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia     Volume:  15     ISSN:  0967-5868     ISO Abbreviation:  J Clin Neurosci     Publication Date:  2008 Dec 
Date Detail:
Created Date:  2008-11-10     Completed Date:  2009-04-09     Revised Date:  2011-03-01    
Medline Journal Info:
Nlm Unique ID:  9433352     Medline TA:  J Clin Neurosci     Country:  Scotland    
Other Details:
Languages:  eng     Pagination:  1340-5     Citation Subset:  IM    
Affiliation:
Department of Neurology, The Canberra Hospital, Australian National University Medical School, Woden ACT 2606, Australia. christian.lueck@act.gov.au
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenal Cortex Hormones / therapeutic use
Antirheumatic Agents / therapeutic use
Australia / epidemiology
Female
Health Surveys*
Humans
Male
Neurology / methods,  statistics & numerical data*
New Zealand / epidemiology
Ophthalmology / methods,  statistics & numerical data*
Optic Neuritis / epidemiology*,  therapy*
Physician's Practice Patterns / classification,  statistics & numerical data*
Questionnaires
Grant Support
ID/Acronym/Agency:
P30 EY006360-25/EY/NEI NIH HHS; P30-EY06360/EY/NEI NIH HHS
Chemical
Reg. No./Substance:
0/Adrenal Cortex Hormones; 0/Antirheumatic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  KIR-HLA intercourse in HIV disease.
Next Document:  Clinical and functional outcomes of anterior cervical discectomy without fusion.